Tamir Tal, CEO, Cordio Medical, explains how AI voice biomarker technology and the advancement of a diagnostic app from a smartphone can transform diagnosis of early diseases.
Read more here.
Tamir Tal, CEO, Cordio Medical, explains how AI voice biomarker technology and the advancement of a diagnostic app from a smartphone can transform diagnosis of early diseases.
![[enVerid in PR Newswire] enVerid HLR® technology solves air pollution challenges for leading business school in China](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
